Venture Capital & Emerging Companies
Viewpoints
Filter by:
Early- and Growth-Stage Companies in Distress: What Directors Need to Know about their Fiduciary Duties
October 8, 2024 | Blog | By Alex Civetta, Tim McKeon
Most high-growth companies find themselves in a race against the clock, trying to use whatever capital they may have to achieve milestones prior to hitting their cash-out date. When markets are tight, as they have been over the past several months, founders and boards confront the reality of a liquidity crisis on a nearly daily basis in their scenario planning. It can come in the form of a potential buyer or investor deciding to walk away from a deal, a current investor experiencing its own liquidity crunch, or unfavorable data coming at an unfavorable time. Whatever the cause, when a company approaches insolvency, it is often an existential event, forcing the board of directors to think carefully about how to help the company make decisions in view of the board’s changing fiduciary duties, as well as how those duties may be impacted by a company’s declining cash position.
Mintz Venture Watch — Volume 7: A Report on Deal Trends from Q1 and Q2 2024
September 27, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in the first half of 2024. During this period, Mintz represented issuers and investors in the technology, life sciences, energy, and other sectors in 73 transactions valued at more than $980 million.
MintzTech Connect: All Things Technology — September 2024
September 18, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers a federal court ruling blocking the nationwide enforcement of the FTC’s noncompete rule, a checklist for foreign companies expanding into the US, and a spotlight on GUDEA, a tech company using AI-driven tools to help companies predict, map, and influence information flows across social networks.
MintzTech Connect Industry News: Spotlight on GUDEA
September 18, 2024 | Article
Read about GUDEA, a technology company with AI-driven tools that enable organizations to predict, map, and influence information flows across social networks before they impact public perception.
Checklist for Foreign Companies Expanding into the US
August 26, 2024 | Advisory | By Kaoru C. Suzuki, Larry P. Naughton, Joshua D. Fox
This article provides a checklist of action items for foreign companies making an initial expansion into the US, covering essential topics like choosing a business structure, navigating laws and regulations concerning immigration, employment, and taxes, and securing funding.
Crossing Borders: Key Considerations for International VC Investments
July 9, 2024 | Advisory | By Kaoru C. Suzuki
This article provides information for international angel investors and venture funds looking to invest in start-ups in the United States, including on investment frameworks like how terms are handled, regulatory considerations, and US tax implications.
Acing Your First Start-up Board Meeting: Board Deck Tips
July 2, 2024 | Alert | By Kaoru C. Suzuki
This article provides a detailed overview of how company founders can create an effective board deck to prepare for a meeting with investor directors.
MintzTech Connect Event Highlight: The Sustainable Media Center
June 13, 2024 | Article
MintzTech Connect: All Things Technology — June 2024
June 13, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers the FTC’s controversial final rule banning most post-employment non-competes, qualified small business stock issues affecting the conversion of an LLC into a corporation, clinical trial innovator Radicle Science, and an event co-sponsored by Mintz and the Sustainable Media Center, which focused on the impact of social media on today’s youth.
MintzTech Connect Industry News: Spotlight on Radicle Science
June 13, 2024 | Article | By Jeremy Glaser, Sophia Fein
Read about Radicle Science, a B-corp transforming the supplement industry’s approach to clinical trials and efficacy validation through virtual trials that greatly expand the scale and diversity of trial participants.
Preparing a VC-Backed Company for an Exit Event
April 22, 2024 | Alert | By Stephen M. Callegari, Stefan Jović
This alert provides an overview of critical steps companies can take to ensure that an M&A exit event runs smoothly, including ensuring internal agreement on the sale, establishing an M&A team, attending to legal housekeeping matters, and carefully reviewing term sheets received from potential bidders.
Important Updates to the New York LLC Transparency Act
April 15, 2024 | Advisory | By Daniel DeWolf, Sophia Fein
The New York LLC Transparency Act, which takes effect on January 1, 2026, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.
From the Edge - MintzEdge Entrepreneur Perspective: Mintz Awards Winners Share Strategies for Success
April 1, 2024 | Podcast | By Jason S. Miller
Join Mintz Corporate and Securities Associate, Jason Miller, in a conversation with Margaret Yu, founder and CEO of Reliacare, and Andrew Gladue, founder and CEO of Plethys.
MintzTech Connect: All Things Technology — March 2024
March 20, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers Corporate Transparency Act compliance requirements, considerations for companies undertaking Section 409A valuations, and Mintz’s year in review of laws impacting employee non-competition, non-solicitation, and non-disclosure agreements.
Essential Annual Actions for Start-up Boards
March 18, 2024 | Alert | By Kaoru C. Suzuki
As a start-up begins to approach its fiscal year-end, company founders need to be mindful of key annual action items for boards, such as the budget, executive compensation, and other administrative actions.
Compliance with the New York LLC Transparency Act Necessary for Many Mintz Clients
March 12, 2024 | Alert | By Daniel DeWolf, Sophia Fein
The New York LLC Transparency Act, which takes effect on December 21, 2024, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.
Client Corner: Meet CEO and COO of Suono Bio, Scott Kellogg & Skip Farinha
March 1, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Suono Bio’s CEO Scott Kellogg and COO Skip Farinha. Scott and Skip discuss the importance of active listening in managing a team, strategies for navigating the medical device approval process in the US, key factors to consider when selecting investors, and insights on managing unforeseen challenges.
Client Corner: Meet Co-founder & CEO of Axoft, Paul Le Floch
February 16, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Paul Le Floch, Co-founder & CEO of Axoft. Paul discusses his journey from growing up in France to becoming a founder and the CEO of a neurotechnology startup. He provides insight into forming Axoft and navigating the fundraising process and offers advice to individuals starting new ventures.
Mintz Venture Watch — Volume 6: A Report on Deal Trends from 2023
February 6, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2023. Mintz represented issuers and investors in the technology, energy, life sciences, and other sectors in more than 130 transactions valued at over $2.6 billion.
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology